Key result
Age-specific epistasis between APOE and LSR reversed the protective effect of the APOE ε2 allele on cholesterol, ApoE, and LDL levels.
Why the study?
Does the LSR polymorphism rs916147 affect blood lipid levels and interact with the APOE common polymorphism in healthy subjects?
Observational (n=2,504)
Does the LSR polymorphism rs916147 affect blood lipid levels and interact with the APOE common polymorphism in healthy subjects?
The study reveals a complex epistatic interaction between LSR and APOE polymorphisms that significantly affects lipid metabolism, highlighting potential new pathways in type III hyperlipidemia and cardiovascular disease.
Answers are grounded in this paper and cite their sources.
LSR rs916147 association with lipid traits is hypothesis-generating; leaves open any role in CVD risk assessment pending validation studies.
The lipolysis stimulated lipoprotein receptor (LSR) is an apolipoprotein (Apo) B and ApoE receptor that participates in the removal of triglyceride‐rich lipoproteins during the postprandial phase. LSR gene is located upstream of APOE, an important risk factor for cardiovascular disease (CVD). Since the APOE common polymorphism significantly affects the variability of lipid metabolism, this study aimed to determine the potential impact of a functional SNP rs916147 in LSR gene on lipid traits in healthy subjects and to investigate potential epistatic interaction between LSR and APOE. Unrelated healthy adults (N = 432) and children (N = 328, <18 years old) from the STANISLAS Family Study were used. Age‐specific epistasis was observed between APOE and LSR, reversing the protective effect of APOE ε2 allele on cholesterol, ApoE and low‐density lipoprotein levels (β: .114, P: .777 × 10−8, β: .125, P: .639 × 10−3, β: .059, P: .531 × 10−3, respectively). This interaction was verified in an independent adult population (n = 1744). These results highlight the importance of the LSR polymorphism and reveal the existence of complex molecular links between LSR and ApoE for the regulation of lipid levels, revealing potential new pathways of interest in type III hyperlipidemia and its involvement in CVD pathology.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2017) conducted an observational in Healthy (n=2,504). LSR functional SNP rs916147 and APOE polymorphism was evaluated on cholesterol, ApoE and low-density lipoprotein levels (β 0.114, p=0.777 × 10−8). Age-specific epistasis between APOE and LSR reversed the protective effect of the APOE ε2 allele on cholesterol, ApoE, and LDL levels.
Synapse has enriched 10 related papers. Consider them for comparative context: